Rosacea: A review

P and T

Volumn 34, Issue 1, 2009, Pages 38-45

  Culp, Brittney ^a   Scheinfeld, Noah ^b,c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADAPALENE; AKNE MYCIN; AMITRIPTYLINE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZELAIC ACID; AZITHROMYCIN; BENZAMYCIN; BENZOYL PEROXIDE; CHLORMADINONE ACETATE PLUS MESTRANOL; CLARITHROMYCIN; CLINDAMYCIN; CLONIDINE; CORTICOSTEROID; DAPSONE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; ERYTHROMYCIN; ETRETIN; HEXACYCLINE; ISOTRETINOIN; IVERMECTIN; KETOCONAZOLE; METRONIDAZOLE; MINOCYCLINE; NALOXONE; OMEPRAZOLE; ONDANSETRON; OXYMETAZOLINE; PENICILLIN G; PERMETHRIN; PIMOZIDE; PREDNISONE; RETINOIC ACID; RETINOID; SEROTONIN UPTAKE INHIBITOR; SOLODYN; SPIRONOLACTONE; SULFACETAMIDE; SULFAMETHOXYPYRIDAZINE; TAZAROTENE; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; CREAM; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG CAPSULE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ERYTHEMA; EUROPE; EYE DISEASE; FLUSHING; FOOD AND DRUG ADMINISTRATION; GEL; HUMAN; IATROGENIC DISEASE; LONG TERM CARE; LUPUS VULGARIS; MEDICAL ETHICS; NONVERBAL COMMUNICATION; PERIORAL DERMATITIS; PHARMACIST; PHARMACIST ATTITUDE; PHOTODERMATOSIS; PHOTOTHERAPY; REVIEW; RISK ASSESSMENT; ROSACEA; SEBORRHEIC DERMATITIS; SEX RATIO; SKIN ALLERGY; SKIN COLOR; SKIN IRRITATION; SKIN SENSITIVITY; TELANGIECTASIA; TOBACCO; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 60549110417     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Rohrich RJ, Griffin JR, Adams WP Jr. Rhinophyma: Review and update. Plast Reconstr Surg 2002;110(3):860-869; quiz, 870.
2. Scheinfeld NS. Rosacea. Skinmed 2006;5:191-194.
3. Halder RM, Brooks HL, Callendar VD. Acne in ethnic skin. Dermatol Clin 2003;21(4).
4. Berg M, Liden S. An epidemiological study of rosacea. Acta Dermatol Venereol 1989;69:419-423.
5. Pray WS, Pray JJ. Differentiating between rosacea and acne. US Pharmacist 2004;29(4).
6. Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther 2006; 19(4):196-201.
7. Shelley WB, Shelley ED. Advanced Dermatologic Therapy II, 2nd ed. Philadelphia: WB Saunders; 2001.
8. Berth-Jones J, Clark SM, Henderson CA. Rosacea and perioral dermatitis. In: Lebwohl M, Heymann WR, Berth-Jones J, et al., eds. Treatment of Skin Disease. London: Mosby; 2002.
9. Rosacea. In: Marks JG, Miller JJ (eds.). Principles of Dermatology, 4th ed. Philadelphia: Elsevier/Saunders; 2006.
10. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51(3);327-341.
11. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991;25:1038-1043.
12. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Exp Opin Pharmacother 2004;1:5-13.
13. Norwood R, Norwood D. Treating rosacea. US Pharmacist 2007; 32(9):45-53.
14. Dressier-Carre M. Acne vulgaris and rosacea. In: Arcangelo VP, ed. Pharmacotherapeutics for Advanced Practice: A Practical Approach. Philadelphia: Lippincott Williams & Wilkins, 2005.
15. Van Zurren EJ, Graber MA, Hollis S, et al. Interventions for rosacea. Cochrane Database Syst Rev 2005(3).
16. Pelle MT, Crawford GH, James WD. Rosacea II: Therapy. J Am Acad Dermatol 2004;51(4):499-512.
17. Nally JB, Berson DS. Topical therapies for rosacea. J Drugs Dermatol 2006;5:23-26.
18. Elewski BE, Flesicher AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidzole gel in the topical treatment of papulopustular rosacea: Results of a randomized trial. Arch Dermatol 2003;139(11):1444-1450.
19. Colon LE, Johnson LA, Gottschalk RW. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. Cutis 2007;79:317-321.
20. Madsen JT, Thormann J, Kerre S, et al. Allergic contact dermatitis to topical metronidazole: Three cases. Contact Dermatitis 2007;56:364-366.
21. Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: A randomized vehicle-controlled double-blind trial. Br J Dermatol 2007;156:728-732.
22. Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol 2007;21:484-490.
23. 1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol 2007; 143(11):1369-1371.
24. Wozniacka A, Wierczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: A pilot study. Clin Exp Dermatol 2005;30(6): 632-635.
25. Callender VD. Acne in ethnic skin: Special considerations for therapy. Dermatol Ther 2004;17(2):184-195.
26. Theobald K, Bradshaw M, Leyden J. Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed 2007;6:221-226.
27. Low-dose doxycycline (Oracea) for rosacea. Med Lett Drugs Ther 2007;49(1252):5-6.
28. Berman B, Perez OA, Zell D. Update on rosacea and anti-inflammatory-dose doxycycline. Drugs Today (Barc) 2007;43:27-34.
29. Fernandez-Obregon A, Patton DL. The role of Chlamydia pneumoniae in the etiology of acne rosacea: Response to the use of oral azithromycin. Cutis 2007;79:163-167.
30. Bakar O, Demircay Z, Yuksel M, et al. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007; 32:197-200.
31. Rebora A. The management of rosacea. Am J Clin Dermatol 2002;3:489-496.
32. Fowler JF. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 2007;6(6);641-645.
33. Larson AA, Goldman MP. Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. J Drugs Dermatol 2007; 6:843-845.
34. Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33:449-454.
35. Blount BW, Pelletier AL. Rosacea: A common, yet commonly overlooked, condition. Am Fam Physician 2002;66(3):435-440.
36. Laqueize S, Czernieleski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat 2007;18(3):158-162.
37. Wu JJ, Weistein GD, Kricorian GJ, et al. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 2007;32(6):693-695.
38. Wu J. Treatment of rosacea with herbal ingredients. J Drugs Dermatol 2006;5(1):29-32.
39. Yu TG, Zheng YZ, Zhu JT, Guo W. Effect of treatment of rosacea in females by Chibixiao recipe in combination with minocycline and spironolactone. Chin J Integr Med 2006;12:277-280.
40. Millikan L. Recognizing rosacea: Could you be misdiagnosing this common skin disorder? Postgrad Med 1999;105(2).
41. Smith K, Leyden JJ. Safety of doxycycline and minocycline: A systematic review. Clin Ther 2005;27(9):1329-1342.
42. Baxi S. OTC products for the treatment of acne. US Pharmacist 2007;32(7):13-17.
43. Pray JJ, Pray WS. Teenagers and acne: The role of the pharmacist. US Pharmacist 2003;28(6).
44. Rochester CD. Drug interactions in dermatology: Are they just skin deep? US Pharmacist 2007;32(4):HS29-HS39.
45. Stone DU, Chodosh J. Ocular rosacea: An update on pathogenesis and therapy. Curr Opin Ophthalmol 2004;15:499-502.
46. Kheirkhah A, Casas V, Li W, et al. Corneal manifestations of ocular Demodex infestation. Am J Ophthalmol 2007;143:743-749.
47. Bormann G, Gaber G, Fischer M, Marsch WC. Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 2001;15:465-467.
48. Aroni K, Tsagroni E, Lazaris AC, et al. Rosacea: A clinicopathological approach. Dermatology 2004;209:177-182.